In this set of experiments we analyzed if an MPN cell line (UKE-1 and SET-2) with the mutation in JAK2 can change the expression of important key genes, important in the hematopoiesis maintenance, in two different healthy mesenchymal cell lines (hTERT and HS5). Here, JAK2 is linked to myeloproliferative disorder.